Balram Bhargava
In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – commencing phase 3 trials based on results from animal studies.
arrow paradox
The idea that trusting in science involves a lot of faith, instead of reason, is lost on most people. More often than not, as a science journalist, I encounter faith through extreme examples – such as the Bloch sphere (used to represent the state of a qubit) or wave functions (‘mathematical
biopolitics
With Covishield in my body, I feel like there is a capillary tube erupting from the Ministry of Health and Family Welfare, and its panoply of attendant bodies vis-à-vis India’s COVID-19 response, soaring across the length of India and plunging into my veins, somewhere in Bangalore. And with every
